These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of the tumor-targeting specific imaging and killing effect of a CEA-targeting nanoparticle in colorectal cancer. Feng Q; Wang SA; Ning B; Xie J; Ding J; Liu S; Ai S; Li F; Wang X; Guan W Biochem Biophys Res Commun; 2024 Jul; 719():150084. PubMed ID: 38733742 [TBL] [Abstract][Full Text] [Related]
4. CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer models. Tiernan JP; Ingram N; Marston G; Perry SL; Rushworth JV; Coletta PL; Millner PA; Jayne DG; Hughes TA Nanomedicine (Lond); 2015; 10(8):1223-31. PubMed ID: 25694062 [TBL] [Abstract][Full Text] [Related]
5. Specific adhesion of carcinoembryonic antigen-bearing colorectal cancer cells to immobilized carcinoembryonic antigen. Levin LV; Griffin TW Cancer Lett; 1991 Nov; 60(2):143-52. PubMed ID: 1657369 [TBL] [Abstract][Full Text] [Related]
6. Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer. da Paz MC; Santos Mde F; Santos CM; da Silva SW; de Souza LB; Lima EC; Silva RC; Lucci CM; Morais PC; Azevedo RB; Lacava ZG Int J Nanomedicine; 2012; 7():5271-82. PubMed ID: 23055733 [TBL] [Abstract][Full Text] [Related]
7. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model. DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840 [TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells. Pereira I; Sousa F; Kennedy P; Sarmento B Int J Pharm; 2018 Oct; 549(1-2):397-403. PubMed ID: 30110619 [TBL] [Abstract][Full Text] [Related]
9. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery. Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721 [TBL] [Abstract][Full Text] [Related]
11. Intra-colonic administration of a polymer-bound NIRF probe for improved colorectal cancer detection during colonoscopy. Kogan-Zviagin I; Shamay Y; Nissan A; Sella-Tavor O; Golan M; David A J Control Release; 2014 Oct; 192():182-91. PubMed ID: 25008468 [TBL] [Abstract][Full Text] [Related]
12. Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells. Abdul-Wahid A; Cydzik M; Fischer NW; Prodeus A; Shively JE; Martel A; Alminawi S; Ghorab Z; Berinstein NL; Gariépy J Int J Cancer; 2018 Oct; 143(8):1963-1977. PubMed ID: 29756328 [TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer. Eftekhar E; Naghibalhossaini F Mol Biol Rep; 2014 Jan; 41(1):459-66. PubMed ID: 24293105 [TBL] [Abstract][Full Text] [Related]
14. scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells. Silveira MJ; Martins C; Cruz T; Castro F; Amorim-Costa Â; Chester K; Oliveira MJ; Sarmento B J Nanobiotechnology; 2023 Oct; 21(1):357. PubMed ID: 37784150 [TBL] [Abstract][Full Text] [Related]
15. Targeted Biodegradable Near-Infrared Fluorescent Nanoparticles for Colorectal Cancer Imaging. Chung SJ; Hadrick K; Nafiujjaman M; Apu EH; Hill ML; Nurunnabi M; Contag CH; Kim T ACS Appl Bio Mater; 2024 Dec; 7(12):7861-7870. PubMed ID: 38574012 [TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors. Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046 [TBL] [Abstract][Full Text] [Related]
17. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma. Guadagni F; Witt PL; Robbins PF; Schlom J; Greiner JW Cancer Res; 1990 Oct; 50(19):6248-55. PubMed ID: 2119252 [TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling. Samara RN; Laguinge LM; Jessup JM Cancer Res; 2007 May; 67(10):4774-82. PubMed ID: 17510406 [TBL] [Abstract][Full Text] [Related]
19. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. Boogerd LSF; Hoogstins CES; Schaap DP; Kusters M; Handgraaf HJM; van der Valk MJM; Hilling DE; Holman FA; Peeters KCMJ; Mieog JSD; van de Velde CJH; Farina-Sarasqueta A; van Lijnschoten I; Framery B; Pèlegrin A; Gutowski M; Nienhuijs SW; de Hingh IHJT; Nieuwenhuijzen GAP; Rutten HJT; Cailler F; Burggraaf J; Vahrmeijer AL Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):181-191. PubMed ID: 29361435 [TBL] [Abstract][Full Text] [Related]
20. Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells. Meller B; Rave-Fränck M; Breunig C; Schirmer M; Baehre M; Nadrowitz R; Liersch T; Meller J Strahlenther Onkol; 2011 Feb; 187(2):120-6. PubMed ID: 21271227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]